1 |
Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer. 2013;21(11):3233-3241. http://dx.doi.org/10.1007/s00520-013-1900-x
DOI
|
2 |
Niscola P, Romani C, Cupelli L, Scaramucci L, Tendas A, Dentamaro T, et al. Mucositis in patients with hematologic malignancies: An overview. Haematologica. 2007;92(2):222-231.
DOI
|
3 |
Larsen J, Nordstrom G, Ljungman P, Gardulf A. Symptom occurrence, symptom intensity, and symptom distress in patients undergoing highdose chemotherapy with stem-cell transplantation. Cancer Nursing. 2004;27(1):55-64.
DOI
|
4 |
Hernandez-Fernandez A, Onate-Sanchez RE, Cabrerizo-Merino MC, de Arriba-de la-Fuente F, Heras-Fernando I, Vicente-Garcia V. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Medicina Oral, Patologia Oral y Cirugia Bucal. 2012;17(1):e94-e101.
|
5 |
Ohbayashi Y, Imataki O, Ohnishi H, Iwasaki A, Ogawa T, Inagaki N, et al. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2008;87(10):837-845. http://dx.doi.org/10.1007/s00277-008-0508-6
DOI
|
6 |
Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, et al. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncology. 2011;47(3):153-162. http://dx.doi.org/10.1016/j.oraloncology.2010.11.019
DOI
|
7 |
Park MH, Park JS. Difference of oral mucositis in hospitalized cancer patients receiving chemotherapy. Asian Oncology Nursing. 2013;13(2):76-84. http://dx.doi.org/10.5388/aon.2013.13.2.76
DOI
|
8 |
Son YJ, Shin YJ, Cho MY, Kim SH, Park OS, Han SY, et al. The development of an oral care protocol for cancer patients receiving chemotherapy and its effects. Journal of Korean Clinical Nursing Research. 2011;17(1):113-122.
|
9 |
Song CE, So HS, Ju D, Kim EJ. Randomized controlled trial for preventing stomatitis and discomfort among acute leukemic patients. Journal of Korean Oncology Nursing. 2011;11(1):33-40. http://dx.doi.org/10.5388/jkon.2011.11.1.33
DOI
|
10 |
Choi SE, Kim HS. Sodium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: A randomized controlled trial. Asian Nursing Research. 2012;6(2):60-66.
DOI
|
11 |
Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. Journal of Clinical Oncology. 2001;19(8):2201-2205.
DOI
|
12 |
Niscola P. Mucositis in malignant hematology. Expert Review of Hematology. 2010;3(1):57-65. http://dx.doi.org/10.1586/ehm.09.71
DOI
|
13 |
Cheng KK. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer. European Journal of Cancer Care. 2008;17(3):306-311. http://dx.doi.org/10.1111/j.1365-2354.2007.00843.x
|
14 |
Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplantation. 2011;46(5):727-732. http://dx.doi.org/10.1038/bmt.2010.184
DOI
|
15 |
Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncology. 2003;39(2):91-100.
DOI
ScienceOn
|
16 |
Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology. 2000;110(2):292-299.
DOI
ScienceOn
|
17 |
Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dental Clinics of North America. 2008;52(1):61-77. http://dx.doi.org/10.1016/j.cden.2007.10.002
DOI
|
18 |
Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. Journal of Clinical Oncology. 2004;22(7):1268-1275. http://dx.doi.org/10.1200/jco.2004.05.147
DOI
ScienceOn
|
19 |
Bolwell BJ, Kalaycio M, Sobecks R, Andresen S, Kuczkowski E, Bernhard L, et al. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplantation. 2002;30(9):587-591. http://dx.doi.org/10.1038/sj.bmt.1703694
DOI
|
20 |
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995-2025. http://dx.doi.org/10.1002/cncr.20162
DOI
ScienceOn
|
21 |
Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Supportive Care in Cancer. 2007;15(5):491-496. http://dx.doi.org/10.1007/s00520-006-0176-9
DOI
|
22 |
Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer. 2000;8(1):33-39.
|
23 |
Eilers J, Million R. Clinical update: Prevention and management of oral mucositis in patients with cancer. Seminars in Oncology Nursing. 2011;27(4):e1-e16. http://dx.doi.org/10.1016/j.soncn.2011.08.001
|
24 |
Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology. 2009;45(12):1015-1020. http://dx.doi.org/10.1016/j.oraloncology.2009.08.006
DOI
ScienceOn
|
25 |
Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Seminars in Oncology. 2003;30(6 Suppl 18):76-83.
|
26 |
Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Supportive Care in Cancer. 2013;21(11):3191-3207. http://dx.doi.org/10.1007/s00520-013-1871-y
DOI
|
27 |
Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, et al. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. Supportive Care in Cancer. 2012;20(5):933-939. http://dx.doi.org/10.1007/s00520-011-1164-2
DOI
|
28 |
Eilers J. Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment. Oncology Nursing Forum. 2004;31(4 Suppl):13-23. http://dx.doi.org/10.1188/04.onf.s4.13-23
|
29 |
Vokurka S, Bystricka E, Scudlova J, Mazur E, Visokaiova M, Vasilieva E, et al. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation. European Journal of Oncology Nursing. 2011;15(5):508-512. http://dx.doi.org/10.1016/j.ejon.2011.01.006
DOI
|
30 |
Strobel ES, Bauchmuller K, Ihorst G, Engelhardt M. Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature. Leukemia and Lymphoma. 2007;48(11):2255-2260. http://dx.doi.org/10.1080/10428190701636492
DOI
|